Introduction
Phagocytosis, digestive processing, and presentation of antigen in complexes with self-histocompatibility molecules, supported by expression of additional immunogenic signals (including monokines, prostaglandins and oxidative radicals), collectively determine the participation of monocytes in the induction of specific immune responses and their concomitant contribution to development and maintenance of immunogenic tissue inflammation. One of the most potent immuno-enhancing members of the monokine family is interleukin-1.
1,2 To exert its immunostimulatory and pro-inflammatory effects, IL-1 has to compete with the other monocyte product, monokine IL-1 receptor antagonist (IL-1ra), for access to its receptors on the surface of the target cell. In contrast to IL-1, IL-1ra is unable to transduce the stimulatory signal; thus, in binding to the receptor, the IL-1ra prevents its activation. 3 -5 Assessments of alterations in the IL-1ra/IL-1 concentration ratio within the humoral environment of responding cells may provide clinically important information on the stage of the ongoing immune response and on the progression of the inflammatory process. In general, the lower values of the IL-1ra/IL-1 ratio characterise the developmental phase, whereas increased values mark the termination of the both processes. 6 -9 The IL-1ra/IL-1 concentration ratio is measurable close to responding cells (in inflammatory tissue fluids) or at distant humoral peripheries (blood serum, spinal cord fluid, urine samples). In this respect, testing sites in the closest humoral vicinity can be expected to yield the most accurate information on the actual functional state of a cellular source of assessed monokines. Moreover, this goal may be gained by direct measurements of respective monokine concentrations (enzyme-linked immunosorbent assay (ELISA) method), or by estimation of the behaviour of other cells that are natural neighbours of monocytes and are primarily dependent on their monokine influence (e.g. the mitogenic proliferative response of T lymphocytes).
The mononuclear cell population isolated from peripheral blood and set-up in culture contains the quantity of monocytes and T cells representative of their respective blood values. Under appropriate experimental conditions, the results of tests performed on the cultures offer a possibility to obtain in vitro insight into the actual functional state of immune cells' in vivo, characteristic for the tested individual.
Other authors and ourselves 10, 11 have previously observed that human blood-derived mononuclear cells, if incubated in microcultures for 24 h without mitogenic stimulation, lose the capacity for proliferative response to subsequent stimulation with PHA, as can be demonstrated at 72 h by measurement of [ 3 H]-thymidine incorporation. Although the number and viability of cells remained undisturbed, any trials, including changes of PHA concentration (from suboptimal to overoptimal doses) or addition of exogenous IL-2, did not induce the proliferative response. Nevertheless, the cells could regain the reactivity if their native culture medium was partially replaced at 24 h with the cell-free medium from a PHA-stimulated culture or if part of it was separately absorbed with autologous lymphocytes and returned to the original cell culture before the stimulation.
These observations suggested that some inhibitory humoral agent had accumulated in culture medium during the 24 h of incubation, and that the level of lymphocyte reactivity regained upon subsequent stimulation with PHA is dependent on the concentration of the putative inhibitory agent.
The aim of the present experiments was to determine the nature of the observed phenomenon in respect of the possible role of monocytes and their products, IL-1 and IL-1ra, and to test for immunodiagnostic purposes the significance of quantifying the lymphocyte response to delayed stimulation with PHA in patients suffering from inflammatory processes.
Materials and methods
Peripheral blood mononuclear cells (PBMC) were isolated by density gradient sedimentation (Ficol/ Hypaque, 1.007 g/ml, Pharmacia LKB, Uppsala, Sweden) of heparinised venous blood samples taken from healthy donors or patients suffering from acute infections of the upper respiratory tract (both sexes, age range 20-40 years). After determination of cell viability, the microcultures were set-up in triplicate in Nuncoln round-bottomed 96-well microplates, as previously described. 10 In brief, the cultures (each containing 10 5 cells in 0.2 ml of RPMI 1640 supplemented with 15% of inactivated autologous serum) were incubated at 37°C in an ASSAB incubator in a humified atmosphere of 5% CO 2 in air for 72 h. In each experiment, several sets of triplicate microcultures were left without stimulation and others were stimulated at 0 h with PHA (HA16, 0.4 m g/culture, optimal dose; Murex Biotech Ltd., Dartford, UK). For the last 16 h of incubation, [ 3 H]-thymidine (3HTdR) (specific activity, 5 Ci/ mM; Amersham, UK) was added into the cultures in a dose of 0.4 m Ci per well. After harvesting the cultures, the measurements of incorporated radioactivity were carried out in a Tri-carb 2100 TR Packard liquid scintillation analyser and the results were expressed as a mean value of disintegrations per minute (dpm) ± SD for each triplicate. Additionally, the volumes of 0.1 ml of cell-free medium (CFM) were removed at 24 h from separate sets of triplicated non-stimulated cultures and replaced with equal volumes of CFM taken from PHA-stimulated cultures. The cultures rearranged on this way were further processed as already described and served for calculation of LM indices according to the formula:
LM index = mean value of dpm in rearranged cultures mean value of dpm in non-stimulated cultures
We have decided to use this formula for the following reasons. The sparse cells in the PBMC population that 'spontaneously' incorporate 3HTdR in vitro have already entered in vivo the S phase of cell cycle and they do not participate in the response of other cells to the subsequent stimulation with mitogen. Under these circumstances, the simple subtraction of the values of radioactivity incorporated by the cells stimulated in entirely different ways does not seem to be well justified. On the contrary, the ratio of mitogen-stimulated to 'spontaneous' incorporation seems to provide adequate information on how many more cells have contributed to the observed total value of incorporated radioactivity. Concomitantly, the samples of CFM removed at 24 h from non-stimulated cultures were frozen and subsequently assessed quantitatively by ELISA for IL1b and IL-1ra content. The assessments were carried out in the universal microplate analyzer Elx800 (Biokom, Poland) with application of respective Quantikine kits (R&D Systems, Abingdon, UK).
In one particular experiment, the combined CFM collected at 24 h from two sets of triplicated nonstimulated cultures (0.6 ml in total) was absorbed for 30 min with 10 6 autologous lymphocytes and, after centrifugation, returned at 0.1 ml per culture into one set of the original triplicated cultures. These were then stimulated with PHA and further processed as already described.
In consecutive experiments, separate sets of triplicated microcultures were treated at 0 h with 20 ng/ml recombinant human IL-1b (Genzyme, Cambridge, MA, USA), 20 ng/ml recombinant human IL-1ra (Serotec, Oxford, UK), 5 m g/ml anti-human IL-1ra neutralising antibody (lot number Z05; R&D Systems), or with 40 m g/ml pure soluble substance of cefaclor (Elli Lilly, Poland). These cultures were further processed as already described to assess the IL-1ra/IL-1b concentration ratio and/or the LM index.
The results were statistically analysed using the Student t-test to estimate the significance of differences (at p < 0.05). Correlations were determined by linear regression analysis.
Results
The viability of cells tested at the end of the cultures remained, in general, at the level of 80% of initial number of cells set in the culture. In several cases of lower cell viability obserbed at the end of the cultures, the results were dicounted. a At 24 h, half the volume (0.1 ml) of cell-free medium was removed and replaced with 0.1 ml of CFM from PHA-stimulated culture. b PHA index = (dpm in cultures stimulated with PHA at 0 h) / (dpm in non-stimulated cultures). c LM index = (dpm in cultures stimulated with PHA at 24 h after the change of medium) / (dpm in non-stimulated cultures). Table 2 . Cultures preincubated for 24 h and then stimulated with PHA: effects of partial absorption of culture medium (cell-free medium (CFM)) with autologous lymphocytes
Half the volume of CFM (6 ´0.1 ml) removed, absorbed for 30 min with 10 6 lymphocytes and volumes of 0.1 ml of CFM returned to the first triplicate of cultures ) ( + PHA ) ( Table 2 .
To determine the influence of chosen monokines on the response of PBMC to delayed stimulation with PHA, a series of experiments were performed in which cultures were supplemented with exogenous IL-1b (20 ng/ml) or IL-1ra (20 ng/ml). The results are presented in Table 3 . As a mean value of 8.2 ± 2.5 of the LM index was found in the PBMC cultures of healthy donors (see Table 5 Table 4 .
In the next series of experiments ( Fig. 1) , performed on PBMC derived from 10 patients suffering from acute tonsillitis, the LM values and IL-1ra/IL-1b concentration ratios were estimated for control microcultures and for microcultures treated with pure substance cefaclor (40 m g/ml). In the cultures treated with cefaclor, significant reductions in the values of the LM index were observed (mean values, 26. cultures; p < 0.01), and these changes were well correlated (r 2 = 0.81) with the changes of the values of IL-1ra/IL-1b concentration ratio (mean values, 7.5 ± 2.3 for control cultures and 35.1 ± 16.9 for cultures treated with cefaclor; p < 0.01).
The results presented in Table 5 compare the LM values, the IL-1b and IL-1ra concentrations, and the IL1ra/IL-1b concentration ratios observed in microcultures of PBMC from healthy donors and from patients with acute inflammation of the upper respiratory tract. The mean value of LM indices observed in the group of patients (18.4 ± 5.8) was significantly higher than the respective value in the group of healthy donors (8.2 ± 2.5). The mean value of the IL1b concentration in the patients' PBMC cultures (633.8 ± 244.5 pg/ml) was also considerably higher than in cultures of healthy donors' PBMC (167.75 ± 89.5 pg/ml). The IL-1ra concentrations were high in healthy donors' (1867.25 ± 806.5 pg/ml) as well as in patients' PBMC cultures (2559.31 ± 914.7 pg/ml), and did not represent statistically significant differences. The calculated IL-1ra/IL-1b concentration ratio was significantly higher for healthy donors (11.13 ± 7.5) than for the patients (4.03 ± 1.76).
Discussion
Since Mitchison's classic 'three mouse experiment' 12 demonstrating T-cell, B-cell and macrophage cooperation in development of the immune response, the immunogenic role of monocytes and other antigen presenting cells (APC) has been extensively investigated and become well recognised. 1,2,13 -14 Antigen presentation is an immunogenic as a complex with self-histocompatibility molecules (MHC class II antigens). This permits the APC (monocytes, macrophages or dendrytic cells) to recruit from the polyclonal pool of immunocompetent T cells the helper-inducer TCD4+ lymphocyte representing a clonal specificity complementary to the presented antigen. Further development of a specific immune response greatly depends on the quality and quantity of additional co-stimulatory signals from the APC whereby they modulate the behaviour of responding cells, 16 -18 In the large repertoire of APC products, there are two possessing distinguishable potential to regulate the proliferative phase of the T-lymphocyte response. One is IL-1, already known for its multiple immunoenhancing and pro-inflammatory effects, 1,2 and the other (the more recently recognised IL-1ra) is a natural inhibitor of the former.
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The population of PBMC contains both APC (monocytes) and T lymphocytes in quantities and with typical functional properties characteristic for the donor. The inactive lymphocytes remaining at the G o stage of their cell cycle do not spontaneously produce any cytokine until reception of mitogenic stimulation. The monocytes, however, produce in vitro the monokine repertoire representative of their in vivo activity.
8 Thus, assessment of the level of proliferative response of T cells co-cultured with monocytes and exposed to their influence prior the mitogenic stimulation should supposedly indicate which of the competitive monokines, IL-1ra or IL-1, is currently gaining the functional preponderance over the competitor. This, in turn, may serve to characterise the actual functional state of the monocytes in question, and, in so doing suggests a role for the use of T lymphocytes as indicator cells.
The results of our experiments on PBMC have confirmed the dependence of the T-lymphocyte response to delayed stimulation with PHA on the proportion of IL-1ra and IL-1b produced by the monocytes into the culture medium before mitogenic stimulation. Non-responding T cells appeared to regain their proliferative ability if the inhibitory influences of IL-1ra were reduced by partial exchange of the medium, or by exposure of the medium to autologous lymphoctes, or by the addition to the culture of anti-IL-1ra antibodies.
The level of regained reactivity, given as the LM value that did not relate to the level of 'normal' response to PHA, also did not correlate directly with the concentration of IL-1b or IL-1ra found in the culture medium, but it did appear to correlate with the changes of IL-1ra/IL1b concentration ratio. The cultures supplemented with the exogenous IL-1b demonstrated increased LM values if control LM values were low (< 6.0) but not if they were high (> 6.0). Conversely, addition of exogenous IL-1ra decreased the high LM values but did not change the low LM values. The results seem to reflect the effects of competition between the added and endogenous IL-1ra and IL-1b for access to IL-1 receptors on target cells.
The next series of experiments were performed to evaluate the possibility of application of the LM index assessments for clinical diagnostic purposes. The cultures of PBMC from 10 patients suffering from acute tonsilitis were set-up and tested for this, as well as for the values of IL-1ra/IL-1b concentration ratio under in vitro influence of cefaclor, the antibiotic usually administered in vivo for treatment of the disease. In vitro addition of cefaclor resulted in significant increase of IL-1ra/IL-1b concentration ratio (from 7.5 ± 2.3 to 35.1 ± 16.9) and in correlated decrease of LM values (from 26.8 ± 8.3 to 11.3 ± 3.2). The close correlation of the changes in the two parameters suggests that assessment of the LM index in PBMC cultures may serve as a suitable and inexpensive test for evaluation of the monocyte immunogenic activity. The suggestion has received further confirmation from the results of assessments of LM values and IL-1ra/IL-1b concentration ratios performed on cultures of PBMC from healthy donors (n = 20) and from patients with acute or exacerbated upper respiratory tract infections (n = 20). The results presented in Table 5 show that the mean LM index value representative for the healthy donor's group (8.2 ± 2.5) is significantly lower than the respective value observed in the patients' group (18.4 ± 5.8) and, reciprocally, the IL-1ra/IL-1b concentration ratio is considerably higher in the healthy donors' PBMC cultures (11.13 ± 5.51) than in the patients' PBMC cultures (4.03 ± 1.76). In the patients' PBMC cultures, both the IL-1b and IL-1ra concentrations were higher than in the healthy donors' cultures, but a relatively high IL-1b concentration appeared to be mainly responsible for the observed diminution in IL-1ra/IL1b ratio.
In conclusion, the proposed modification of procedure based on delayed stimulation with PHA and appropriate pre-arrangements of the culture medium in human PBMC microcultures seems to offer a relatively simple and inexpensive method for conveniently assessing monocyte immunogenic activity. The method of LM assay would appear to be prospectively useful for diagnostic evaluation of monocyte influence on the development of tissue inflammatory processes and on the lymphocyte proliferative response. Supposedly, the LM assay may also find application in clinical monitoring of the potency of different immunotropic drugs for influencing the monocyte functional state.
